We are live on ! Find out more
ASLN

ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN

Delisted

ASLN was delisted on the 18th of July, 2024.

Back to rankings

41 hedge funds and large institutions have $88.7M invested in ASLAN Pharmaceuticals Limited American Depositary Shares in 2021 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

975% more capital invested

Capital invested by funds: $8.25M → $88.7M (+$80.4M)

242% more funds holding

Funds holding: 12 → 41 (+29)

0% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 5

Holders
41
Holders Change
+29
Holders Change %
+241.67%
% of All Funds
0.72%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
29
Increased
5
Reduced
5
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RI
RTW Investments
New York
+$10.3M
2
VC
Vivo Capital
California
+$9M
3
O
OrbiMed
New York
+$7.98M
4
LGM
Logos Global Management
California
+$7.29M
5
MP
Mangrove Partners
Connecticut
+$6.9M

Top Sellers

Rank Fund Capital Flow
1
IC
Ikarian Capital
Texas
-$2.48M
2
BFM
Boothbay Fund Management
New York
-$255K
3
Renaissance Technologies
Renaissance Technologies
New York
-$210K
4
Morgan Stanley
Morgan Stanley
New York
-$118K
5
UBS Group
UBS Group
Switzerland
-$2.03K
Name Holding Trade Value Shares
Change 		Change in
Stake
RI
1
RTW Investments
New York
$10.9M +$10.3M +81,250 New
VC
2
Vivo Capital
California
$9.52M +$9M +71,023 New
O
3
OrbiMed
New York
$8.44M +$7.98M +63,000 New
LGM
4
Logos Global Management
California
$7.71M +$7.29M +57,500 New
MP
5
Mangrove Partners
Connecticut
$7.3M +$6.9M +54,452 New
LM
6
Luminus Management
Texas
$5.88M +$5.56M +43,845 New
Temasek Holdings
7
Temasek Holdings
Singapore
$5.62M – – –
SCM
8
Sio Capital Management
New York
$4.85M +$177K +1,397 +4%
ACM
9
Asymmetry Capital Management
California
$4.53M +$4.28M +33,814 New
Millennium Management
10
Millennium Management
New York
$4.17M +$3.95M +31,157 New
SM
11
Sabby Management
Florida
$2.74M +$2.59M +20,429 New
DCM
12
DAFNA Capital Management
California
$2.27M +$2.15M +16,938 New
Citadel Advisors
13
Citadel Advisors
Florida
$2.19M +$1.95M +15,414 +1,715%
PIM
14
Platinum Investment Management
Australia
$1.73M – – –
DMK
15
David M. Knott
$1.47M +$1.39M +10,935 New
MIM
16
Monashee Investment Management
Massachusetts
$1.41M +$1.33M +10,500 New
Goldman Sachs
17
Goldman Sachs
New York
$1.36M +$1.29M +10,187 New
PHP
18
Parkman Healthcare Partners
Connecticut
$1.09M +$1.03M +8,125 New
Renaissance Technologies
19
Renaissance Technologies
New York
$866K -$210K -1,661 -20%
AAA
20
Affinity Asset Advisors
New York
$670K +$634K +5,000 New
MA
21
MYDA Advisors
New York
$670K +$634K +5,000 New
CCM
22
CAAS Capital Management
New York
$503K +$475K +3,750 New
BFM
23
Boothbay Fund Management
New York
$439K -$255K -2,014 -38%
Barclays
24
Barclays
United Kingdom
$431K +$407K +3,215 New
MS
25
Maven Securities
Jersey
$395K +$380K +2,996 New
1
2

ASLN Hedge Fund Activity: Q1 2021 in Review

41 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) for Q1 2021, worth a combined $88.7M — up 975% from $8.25M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new ASLN positions and 0 closed out — a net gain of 29 holders — while 5 added to existing stakes and 5 trimmed.

The largest buyer was RTW Investments, opening a new position worth an estimated $10.3M. The largest seller was Ikarian Capital, cutting an estimated $2.48M.

  • 41 institutional investors held ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) as of Q1 2021, up from 12 in Q4 2020.
  • Funds reported $88.7M of ASLAN Pharmaceuticals Limited American Depositary Shares stock for Q1 2021, up 975% quarter-over-quarter.
  • 29 funds opened new ASLAN Pharmaceuticals Limited American Depositary Shares positions in Q1 2021 and 0 closed out, a net change of +29 holders.
  • The largest ASLAN Pharmaceuticals Limited American Depositary Shares buyer in Q1 2021 was RTW Investments, an estimated $10.3M added.
  • The largest ASLAN Pharmaceuticals Limited American Depositary Shares seller in Q1 2021 was Ikarian Capital, an estimated $2.48M sold.

Based on aggregated 13F filings for Q1 2021.